ℹ️
🇬🇧
Search
Search for publications relevant for "Iron chelation"
Iron chelation
Publication
Class
Person
Publication
Programmes
Export current view
publication
New iron chelators in anthracycline-induced cardiotoxicity
2007 |
Publication without faculty affiliation
publication
In vitro characteristics of 1-phenyl-3-methyl-4-acylpyrazol-5-ones iron chelators
2012 |
Faculty of Pharmacy in Hradec Králové
publication
In vitro analysis of iron chelating activity of flavonoids
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Cardioprotective Potential of Iron Chelators and Prochelators
2019 |
Faculty of Pharmacy in Hradec Králové
publication
Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity
+1
Publication without faculty affiliation
publication
Iron chelation in the treatment of neurodegenerative diseases
2016 |
First Faculty of Medicine
publication
Study of novel potentially cardioprotective iron chelators in the model of daunorubicin-induced chronic cardiomyopathy in rabbits
Publication without faculty affiliation
publication
Use of the iron-chelating agents in the prevention of the oxidative stress-induced heart injury
Publication without faculty affiliation
publication
Prevention of free oxygen radicals'-induced myocardial injury with various iron chelators
Publication without faculty affiliation
publication
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH)
2007 |
Publication without faculty affiliation
publication
Utilization of CE and MEKC for separation of deferiprone and its iron chelate
2007 |
Faculty of Science
publication
The novel iron chelator, 2-pyridylcarboxaldehyde-2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity
2009 |
Central Library of Charles University
publication
The novel iron chelator, 2-pyridylcarboxaldehyde-2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity
2009 |
First Faculty of Medicine
publication
Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity
2007 |
Publication without faculty affiliation
publication
Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury
2010 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury
2010 |
Central Library of Charles University
publication
The effects of iron chelators from the isonicotinoyl hydrazone group on the biochemical and haematological parameters and the influence of the chronic anthracycline toxicity in the rabbits
Publication without faculty affiliation
publication
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
2008 |
Central Library of Charles University
publication
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
2008 |
Faculty of Medicine in Hradec Králové
publication
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury
2014 |
Faculty of Pharmacy in Hradec Králové
publication
HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study
+1
2006 |
Faculty of Medicine in Hradec Králové
publication
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
2007 |
Publication without faculty affiliation
publication
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
2007 |
First Faculty of Medicine
publication
Flavonoids as protectors against doxorubicin cardiotoxicity: role of iron chelation, antioxidant activity and inhibition of carbonyl reductase
2007 |
Publication without faculty affiliation
publication
Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity
2006 |
Faculty of Medicine in Hradec Králové
publication
Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates
2004 |
Faculty of Pharmacy in Hradec Králové